VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 365 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $688,000 | -16.1% | 48,007 | +1.2% | 0.00% | -20.0% |
| Q2 2017 | $820,000 | +25.8% | 47,423 | -19.8% | 0.01% | +25.0% |
| Q1 2017 | $652,000 | -0.5% | 59,099 | +31.0% | 0.00% | -20.0% |
| Q4 2016 | $655,000 | +3.0% | 45,099 | +74.1% | 0.01% | 0.0% |
| Q3 2016 | $636,000 | +42.6% | 25,903 | +17.0% | 0.01% | +25.0% |
| Q2 2016 | $446,000 | +15.2% | 22,143 | +50.4% | 0.00% | +33.3% |
| Q1 2016 | $387,000 | -47.4% | 14,721 | +103.3% | 0.00% | -57.1% |
| Q4 2015 | $736,000 | -67.5% | 7,240 | -43.0% | 0.01% | -70.8% |
| Q3 2015 | $2,266,000 | -59.6% | 12,702 | -49.7% | 0.02% | -57.1% |
| Q2 2015 | $5,608,000 | +115.4% | 25,245 | +92.7% | 0.06% | +107.4% |
| Q1 2015 | $2,603,000 | +39.7% | 13,104 | +0.7% | 0.03% | +28.6% |
| Q4 2014 | $1,863,000 | +7.4% | 13,016 | -1.6% | 0.02% | 0.0% |
| Q3 2014 | $1,735,000 | +0.8% | 13,222 | -3.2% | 0.02% | 0.0% |
| Q2 2014 | $1,722,000 | -7.8% | 13,654 | -3.6% | 0.02% | -19.2% |
| Q1 2014 | $1,867,000 | -4.2% | 14,163 | -14.6% | 0.03% | -7.1% |
| Q4 2013 | $1,948,000 | +45.7% | 16,594 | +29.5% | 0.03% | +27.3% |
| Q3 2013 | $1,337,000 | +51.2% | 12,812 | +24.8% | 0.02% | +37.5% |
| Q2 2013 | $884,000 | – | 10,270 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |